Published in J Clin Microbiol on April 14, 2010
Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2013) 11.31
Utility of matrix-assisted laser desorption ionization-time of flight mass spectrometry following introduction for routine laboratory bacterial identification. J Clin Microbiol (2011) 2.73
Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin Microbiol Rev (2013) 2.34
Modern clinical microbiology: new challenges and solutions. Nat Rev Microbiol (2013) 1.81
Rapid Diagnosis of Lung Tumors, a Feasability Study Using Maldi-Tof Mass Spectrometry. PLoS One (2016) 1.39
MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol (2015) 1.26
Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratories. J Clin Microbiol (2012) 1.21
Rapid detection of Salmonella sp. by means of a combination of selective enrichment broth and MALDI-TOF MS. Eur J Clin Microbiol Infect Dis (2011) 1.17
Comparison of an in-house method and the commercial Sepsityper™ kit for bacterial identification directly from positive blood culture broths by matrix-assisted laser desorption-ionisation time-of-flight mass spectrometry. Eur J Clin Microbiol Infect Dis (2012) 1.16
Rapid identification of Cryptococcus neoformans and Cryptococcus gattii by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2011) 1.15
Emerging technologies for the clinical microbiology laboratory. Clin Microbiol Rev (2014) 0.98
Leptospira spp. strain identification by MALDI TOF MS is an equivalent tool to 16S rRNA gene sequencing and multi locus sequence typing (MLST). BMC Microbiol (2012) 0.97
MALDI-TOF mass spectrometry is a fast and reliable platform for identification and ecological studies of species from family Rhizobiaceae. PLoS One (2011) 0.93
Promising new assays and technologies for the diagnosis and management of infectious diseases. Clin Infect Dis (2012) 0.90
In situ identification of plant-invasive bacteria with MALDI-TOF mass spectrometry. PLoS One (2012) 0.89
Detection of extended-spectrum-β-lactamase-producing Escherichia coli ST131 and ST405 clonal groups by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2014) 0.85
Rapid identification of Bacillus anthracis spores in suspicious powder samples by using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Appl Environ Microbiol (2013) 0.84
Direct Identification of Urinary Tract Pathogens From Urine Samples Using the Vitek MS System Based on Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. Ann Lab Med (2015) 0.84
Rapid urine preparation prior to identification of uropathogens by MALDI-TOF MS. Eur J Clin Microbiol Infect Dis (2015) 0.83
Pretreatment of urine samples with SDS improves direct identification of urinary tract pathogens with matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2013) 0.83
Gram-stain plus MALDI-TOF MS (Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry) for a rapid diagnosis of urinary tract infection. PLoS One (2014) 0.82
Targeted Treatment for Bacterial Infections: Prospects for Pathogen-Specific Antibiotics Coupled with Rapid Diagnostics. Tetrahedron (2015) 0.82
Subtype determination of Blastocystis isolates by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS). Eur J Clin Microbiol Infect Dis (2013) 0.82
Diagnosing inflammation and infection in the urinary system via proteomics. J Transl Med (2015) 0.81
MALDI-ToF mass spectrometry for the rapid diagnosis of cancerous lung nodules. PLoS One (2014) 0.81
Comparative evaluation of Vitek 2 identification and susceptibility testing of urinary tract pathogens directly and isolated from chromogenic media. Eur J Clin Microbiol Infect Dis (2013) 0.81
Confounding factors and genetic polymorphism in the evaluation of individual steroid profiling. Br J Sports Med (2014) 0.79
Direct Identification of Urinary Tract Pathogens from Urine Samples, Combining Urine Screening Methods and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry. J Clin Microbiol (2016) 0.79
A real-time PCR-based semi-quantitative breakpoint to aid in molecular identification of urinary tract infections. PLoS One (2013) 0.79
MALDI-TOF MS performance compared to direct examination, culture, and 16S rDNA PCR for the rapid diagnosis of bone and joint infections. Eur J Clin Microbiol Infect Dis (2016) 0.78
Automated pangenomic analysis in target selection for PCR detection and identification of bacteria by use of ssGeneFinder Webserver and its application to Salmonella enterica serovar Typhi. J Clin Microbiol (2012) 0.78
Use of rapid diagnostic techniques in ICU patients with infections. BMC Infect Dis (2014) 0.78
Aerococcus urinae: a possible reason for malodorous urine in otherwise healthy children. Eur J Pediatr (2014) 0.78
Optimizing antimicrobial therapy in critically ill patients. Infect Drug Resist (2014) 0.77
Comparison of the accuracy of matrix-assisted laser desorption ionization-time of flight mass spectrometry with that of other commercial identification systems for identifying Staphylococcus saprophyticus in urine. J Clin Microbiol (2013) 0.76
Similar Neutrophil-Driven Inflammatory and Antibacterial Responses in Elderly Patients with Symptomatic and Asymptomatic Bacteriuria. Infect Immun (2015) 0.76
Recent advances in bacteria identification by matrix-assisted laser desorption/ionization mass spectrometry using nanomaterials as affinity probes. Int J Mol Sci (2014) 0.75
New and developing diagnostic technologies for urinary tract infections. Nat Rev Urol (2017) 0.75
Direct Detection and Identification of Bacterial Pathogens from Urine with Optimized Specimen Processing and Enhanced Testing Algorithm. J Clin Microbiol (2017) 0.75
Rapid phenotypic antimicrobial susceptibility testing using nanoliter arrays. Proc Natl Acad Sci U S A (2017) 0.75
Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis (2009) 16.51
Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am (1997) 5.27
Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol (2000) 4.26
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to 16S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol (2008) 4.18
Characterization of intact microorganisms by MALDI mass spectrometry. Mass Spectrom Rev (2002) 3.98
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol (2009) 3.45
Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol (2008) 2.82
The urine dipstick test useful to rule out infections. A meta-analysis of the accuracy. BMC Urol (2004) 2.56
Rapid identification and typing of listeria species by matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl Environ Microbiol (2008) 2.46
Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Clin Microbiol Infect (2009) 2.04
Challenging the problem of clostridial identification with matrix-assisted laser desorption and ionization-time-of-flight mass spectrometry (MALDI-TOF MS). Anaerobe (2008) 2.03
Rapid classification and identification of salmonellae at the species and subspecies levels by whole-cell matrix-assisted laser desorption ionization-time of flight mass spectrometry . Appl Environ Microbiol (2008) 1.86
[MALDI-TOF mass spectrometry to identify clinical bacterial isolates: evaluation in a teaching hospital in Lille]. Pathol Biol (Paris) (2009) 1.08
Identification of Brucella by MALDI-TOF mass spectrometry. Fast and reliable identification from agar plates and blood cultures. PLoS One (2010) 1.20
Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro. Int J Antimicrob Agents (2009) 0.95
[Identifying bacteria using a matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometer. Comparison with routine methods used in clinical microbiology laboratories]. Enferm Infecc Microbiol Clin (2010) 0.94
MALDI-TOF mass spectrometry is a fast and reliable platform for identification and ecological studies of species from family Rhizobiaceae. PLoS One (2011) 0.93
[Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women]. Enferm Infecc Microbiol Clin (2004) 0.86
Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus. Clin Chem Lab Med (2004) 0.82
Clinical evaluation of a microsphere bead-based flow cytometry assay for the simultaneous determination of anti-thyroid peroxidase and anti-thyroglobulin antibodies. Clin Biochem (2005) 0.82
Functional specific roles of H-ras and N-ras. A proteomic approach using knockout cell lines. Electrophoresis (2012) 0.79
Atypical yeasts identified as Saccharomyces cerevisiae by MALDI-TOF MS and gene sequencing are the main responsible of fermentation of chicha, a traditional beverage from Peru. Syst Appl Microbiol (2013) 0.79
Urinary levels of regenerating islet-derived protein III β and gelsolin differentiate gentamicin from cisplatin-induced acute kidney injury in rats. Kidney Int (2010) 0.78
Clinical evaluation of a new automated anti-dsDNA fluorescent immunoassay. Clin Chem Lab Med (2002) 0.78
[Reliability of MALDI-TOF mass spectrometry in the identification of anaerobic bacteria]. Enferm Infecc Microbiol Clin (2012) 0.78
Antinuclear antibodies (ANA) screening by enzyme immunoassay with nuclear HEp-2 cell extract and recombinant antigens: analytical and clinical evaluation. Clin Biochem (2002) 0.78
MALDI-TOF mass spectrometry as a tool for differentiation of Bradyrhizobium species: application to the identification of Lupinus nodulating strains. Syst Appl Microbiol (2013) 0.77
Increased urinary excretion of albumin, hemopexin, transferrin and VDBP correlates with chronic sensitization to gentamicin nephrotoxicity in rats. Toxicology (2012) 0.77
Identification of fungal clinical isolates by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry. Rev Esp Quimioter (2013) 0.77
Unveiling the rat urinary proteome with three complementary proteomics approaches. Electrophoresis (2013) 0.76
Role of Pharmacogenetics in Improving the Safety of Psychiatric Care by Predicting the Potential Risks of Mania in CYP2D6 Poor Metabolizers Diagnosed With Bipolar Disorder. Medicine (Baltimore) (2016) 0.75
Interleukin-10 and acute coronary syndromes. Am J Med (2012) 0.75
Biological variability of thyroid autoantibodies (anti-TPO and anti-Tg) in clinically and biochemically stable patients with autoimmune thyroid disease. J Clin Lab Anal (2002) 0.75
Effectiveness of different methods for anti-Sm antibody identification. A multicentre study. Clin Chem Lab Med (2005) 0.75
[Is it possible to handle genitourinary system infections in our area with empirical treatment, following recommendations from recent guidelines?]. Rev Esp Quimioter (2013) 0.75
Cytosolic proteome of Kluyveromyces lactis affected by the multidrug resistance regulating transcription factor KlPdr1p. J Proteomics (2012) 0.75